Newsroom

Thanks to a new Phase 2 Small Business Innovation Research (SBIR) award from the National Institutes of Health, Temple researchers have the opportunity to further explore the therapeutic potential of a CBD analog known as KLS-13019.

When leaders of the Temple Emergency Action Corps (TEAC) learned that flights carrying Afghan evacuees would be arriving soon at the Philadelphia International Airport, the students at the Lewis Katz School of Medicine sprang into action to do what they do best – to lend a hand wherever they were needed.

Infection is the most common cause of hemolysis in G6PD-deficient individuals, but certain foods and medications may precipitate the destruction of blood cells, especially in children. Ibuprofen, commonly used for pain relief in pediatric medicine, is included on the list of suspected hemolysis-inducing drugs in G6PD-deficient children. But a recent literature review by researchers at the Lewis Katz School of Medicine suggests that it should be removed from the list – ibuprofen very rarely causes hemolytic anemia in children with G6PD deficiency.